Show simple item record

Withdrawal of a drug from the market: what should the prescriber do?

dc.contributor.authorRoss-Degnan, Dennis
dc.contributor.authorSoumerai, Stephen B.
dc.contributor.authorFortess, Eric E.
dc.contributor.authorGurwitz, Jerry H.
dc.date2022-08-11T08:09:21.000
dc.date.accessioned2022-08-23T16:27:27Z
dc.date.available2022-08-23T16:27:27Z
dc.date.issued1994-10-26
dc.date.submitted2009-09-29
dc.identifier.citationJAMA. 1994 Oct 26;272(16):1253.
dc.identifier.issn0098-7484
dc.identifier.pmid7933365
dc.identifier.pmid7933365
dc.identifier.urihttp://hdl.handle.net/20.500.14038/36789
dc.language.isoen_US
dc.publisherAmerican Medical Association
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7933365&dopt=Abstract">Link to article in PubMed</a>
dc.relation.urlhttp://jama.ama-assn.org/cgi/reprint/272/16/1253
dc.subjectDrug Approval
dc.subjectDrug Utilization
dc.subjectProduct Surveillance, Postmarketing
dc.subjectUnited States
dc.subjectUnited States Food and Drug Administration
dc.subjectHealth Services Research
dc.subjectMedicine and Health Sciences
dc.titleWithdrawal of a drug from the market: what should the prescriber do?
dc.typeLetter to the Editor
dc.source.journaltitleJAMA : the journal of the American Medical Association
dc.source.volume272
dc.source.issue16
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/meyers_pp/151
dc.identifier.contextkey1019633
dc.identifier.submissionpathmeyers_pp/151
dc.contributor.departmentDepartment of Medicine, Division of Geriatric Medicine
dc.contributor.departmentMeyers Primary Care Institute


This item appears in the following Collection(s)

Show simple item record